Stay updated on GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, signaling an updated release. The 'Back to Top' link has been removed, a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T21:54:33.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T18:57:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific medical terms related to lung diseases and the facility name and location, while removing various location-related terms and some medical classifications.
    Difference
    2%
    Check dated 2025-08-31T12:21:40.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:41:23.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:32:14.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-02T19:27:57.000Z thumbnail image

Stay in the know with updates to GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.